Skip to content

'Study on infant Adiposity development To Understand the Role of early life Nutrition - the Sophia Saturn Study'

'Study on infant Adiposity development To Understand the Role of early life Nutrition - the Sophia Saturn Study' - The Sophia Saturn Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54727
Enrollment
234
Registered
2018-04-20
Start date
2019-06-08
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Overweight

Interventions

Intervention: Nuturis formula feeding, start within 6 weeks after birth until 6 months of age Control: Standard formula feeding, start within 6 weeks after birth until 6 months of age

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
No minimum to 11 Years

Inclusion criteria

Inclusion criteria: - Participation in the Sophia Pluto Study (MEC-2012-164) - Parents have decided to start formula feeding - Healthy, full-term infants (gestational age >= 37 weeks) - Children with a neonatal period without severe asphyxia (defined as an Apgar score

Exclusion criteria

Exclusion criteria: - Maternal use of corticosteroids during pregnancy - Pregnant women/parents known to have other significant medical condition (including during pregnancy) that might interfere with the study or know to affect intra-uterine growth as per investigator's clinical judgement - Incapability of the parents to comply with the study protocol - Confirmed intra-uterine infection - Infants with chromosomal disorders, known syndromes and serious dismorphic symptoms suggestive for a (yet unknown) syndrome - Any endocrine or metabolic disorder such as diabetes mellitus, diabetes insipidus, hypothyroidism or inborn errors of metabolism - Infants known to have current or previous illnesses/conditions or intervention which could interfere with the study, such as certain medication (e.g. cortical steroids) or major surgery, as per investigator's clinical judgement

Design outcomes

Primary

MeasureTime frame
The main study parameter is change in fat mass index from 6 to 12 months of age.

Secondary

MeasureTime frame
Secondary, associations with other body composition parameters (fat mass, lean mass, fat mass percentage, subcutaneous and visceral fat mass), anthropometric measurements (e.g. weight, length, weight-for-length, BMI and skinfolds SD), metabolic biomarkers (e.g. serum lipids, satiety hormones), eating behavior and neurocognitive development will be investigated.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)